6 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 1 | Terminated 1 |
Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Mechanisms of Action in Superpower Glass Superpower Glass - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Terminated | Stanford University | 20 | 2019-09-04 | 2023-09-05 |
| Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Trichuris suis ova, Placebo - Autism | Phase 2 | Terminated | Coronado Biosciences, Inc. | 23 | 2014-05-01 | 2015-11-04 |
| Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. Transcranial Magnetic Stimulation - Autism | Phase 2 | Terminated | Brainsway | 20 | 2013-01-23 | 2018-04-17 |
| Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Memantine Hydrochloride (HCl) - Autism Spectrum Disorder (ASD), Autism | Phase 2 | Terminated | Forest Laboratories | 747 | 2012-10-01 | 2015-02-16 |
| A Folinic Acid Intervention for Autism Spectrum Disorders Folinic Acid and placebo, Folinic Acid - Autism Spectrum Disorder, Autistic Disorder | Phase 2 | Terminated | University of Arkansas | 99 | 2012-05-01 | 2017-10-17 |
| Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism transcranial magnetic stimulation - Autism, Asperger Disorder | Phase 2 | Terminated | New York State Psychiatric Institute | 10 | 2008-11-01 | 2017-03-24 |
Autistic Disorder (6) · Autism Spectrum Disorder (4) · Asperger Syndrome (3) · Child Development Disorders, Pervasive (1)
Mental Disorders (6) · Neurodevelopmental Disorders (6) · Child Development Disorders, Pervasive (5) · Autism Spectrum Disorder (2)
Transcranial Magnetic Stimulation (2) · Leucovorin (1) · Memantine (1)
Brainsway (1) · Coronado Biosciences, Inc. (1) · Forest Laboratories (1) · New York State Psychiatric Institute (1) · Stanford University (1) · University of Arkansas (1)
United States (5) · Belgium (1) · Canada (1) · Colombia (1) · Estonia (1) · France (1) · Hungary (1) · Iceland (1) · Israel (1) · Italy (1) · New Zealand (1) · Poland (1) · Serbia (1) · South Africa (1) · South Korea (1)
Alexandra Sporn, MD (1) · Dennis P Wall, PhD (1) · Jordan Lateiner, MS, MBA (1) · Richard E Frye, M.D./Ph.D. (1)